RTX vs XTNT · P/E 36, rev $88.60B vs rev $133.9M
RTX Corporation (RTX) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the RTX and XTNT stock pages for the full models.
Not investment advice.